Seventh meeting of theUNAIDS monitoring and evaluation ...



SEVENTH MEETING OF THE UNAIDS MONITORING AND EVALUATION REFERENCE GROUP (MERG)

Geneva 28-29 July 2003

Switzerland

DRAFT SUMMARY REPORT

TABLE OF CONTENTS

1. Introduction……………………………………………………….…………….3

2. Objectives of the meeting………………………………………………..……...3

3. Main points/comments made and conclusions reached during

discussions on presentations........................………………..…………………..4

3.1. Indicator guidelines discussion points………….…...……………………………………..4

3.2. Working groups…………………………………….…………………………………...….5

3.3. UNGASS Country reports………………………….……………………………………...6

3.4. Survey on coverage rates for essential services:

Preliminary results of the AIDS Program Index (API) second round….……………6

3.5. Global AIDS M&E Support Team (GAMET)…….…………………………………..….6

3.6. Global Fund to fight AIDS, TB, and Malaria (GFATM)……………….…………..…..76

3.7. Country Response Information System (CRIS)……………………………………..…....77

3.8. Estimates and modelling…………………………………………………………………..87

3.9. UN System Strategic Plan (UNSSP)……………………………………………………...87

4. New M&E challenges

4.1. MERG specific……………………………………………………………....……….….…87

4.2. General……………………………………………………………………....……….……......98

4.3. Immediate Actionable Items…………………………………………………….………...9

ANNEXES

Annex 1. Working Groups on indicators, summaries

submitted by rapporteurs

A. Young People

B. PMTCT

C. Care and Support

Annex 21. Provisional Agenda

Annex 32. List of Participants

Annex Annex 3. Working group summaries4. Unable to Attend

1. Introduction

The purpose of this report is to provide a summary of the issues addressed during the seventh meeting of the UNAIDS Monitoring and Evaluation Reference Group (MERG), held in Geneva during 28 – 29 July, 2003. The outline of the report follows (to the extent possible) the meeting agenda (see Annex 2 1).

A diverse set of monitoring and evaluation (M&E) experts individuals were invited to participate in the meeting, representing academic/research institutes, bilateral agencies, the Global Fund to Fight AIDS, TB and Malaria Secretariat (GFATM), national governments, NGOs, US funded projects, UNAIDS Cosponsors, other UN agencies, and UNAIDS Secretariat (see Annex 3 2).

After a brief self-introduction by each participant, Kathleen Cravero (Deputy Director, UNAIDS) welcomed the participants. Ms. Cravero emphasized the unique position of the MERG as an informal group of the Programme Coordination Board (PCB)—that enables the group to provides guidance and direction on the harmonization of mMonitoring and evaluation &E approaches. She also emphasised that M&E is one of the five key UNAIDS functions and that the status of the MERG needs to be further clarified.

The seventh MERG was chaired by Dr. Paul DeLay (Director, Monitoring & Evaluation UNAIDS Secretariat). In his remarks, PaulDr. DeLay spoke about how the MERG has evolved as an M&E resource group. Initially, the role of the MERG was to advise the Secretariat and the PCB on the monitoring and evaluation of UNAIDS’ activities, but over time, the MERG has expanded its mandate to include the review and endorsement of new indicators, the standardization of indicators and surveillance methodologies, and to advise the global community on monitoring and evaluation systems at global and country level. The MERG is now viewed as one of the pre-eminent resource groups on monitoring and evaluating the response to the HIV/AIDS pandemic.and stated that its recommendations are highly regarded.

The provisional agenda was next reviewed and agreed upon.

The sections that follow will cover the (2) objectives of the seventh MERG; present the (3) main points/comments made and conclusions reached during the discussions on the presentations; and (4) summarize the identified M&E challenges – MERG specific, and general to the field of M&E of HIV/AIDS program/projects along with the immediate actionable items.

This MERG meeting report and the e presentations delivereddelivered will be made available in on October 2003 at the UNAIDS M&E webpage: on 1 September, 2003 under 7th MERG meeting.

2. Objectives of the meeting

The objectives of the seventh MERG were to: i) review and approve new indicator guidelines; ii) review current global reporting efforts and activities to support to country monitoring and evaluation programs;provide an up-date on M&E activities; iii) review/revise the scope of work and composition of theclarify the role of the MERG as an M&E resource group.

3. Main points/comments made and conclusions reached during discussions on presentations

3.1. Indicator guidelines discussion points

The focus of this section was on indicators for National AIDS Programmes and/or National AIDS Commissions national AIDS prevention and control programs for the following groups/areas: young people; orphans and vulnerable children (OVC); care and support; injecting drug use (IDU); and, PMTCT.

Young people:

• The reliability of reporting through school-based surveys tends to be inadequate and/or weak.

• The relevance of indicators depends on how well a program is defined.

• Age-group should determine the selection of the indicator set.

• Gender stratification should be taken into account.

• The UNGASS Core Indicators should be widely promoted.

• Clear reference to other guidelines should be made as a way to avoid overlap.

• Reporting on the 10 to 14 year old age cohorts may have questionable validity. More work needs to be done with these younger age groups to determine the optimum methods for ascertaining risk behaviours.

OVC:

• There are different definitions of “vulnerability” in the OVC and the Care and Support guidelines. A common understanding of vulnerability is necessary.

• Currently, the most useful indicator for orphans is school attendance.

• There is consideration of changing the definition of OVC to extend the age range to 18 year old.o.

Care and Support:

• Gender issues should be taken into account when determining level of access to treatment.

• There is a need for greater synchronisation of methods - frequency of surveys and responsibilities, for example, home-based-care and orphan data collection could be carried out by the same researchers.

• There is a need to address the lack of focus on the private sector.

• The human capacity indicator should be reconsidered.

• Concerns were expressed about measuring quality of services and not assessing traditional health care seeking behaviour.

IDU:

• With regards to HIV/AIDS, it is more important to study IDU than other drug use.

• With regards to UNGASS Core Indicators, there is a need to expand the coverage indicator, hence, expand the indicator on condom to use to include IDU.make the indicator on coverage the core one and the indicator on IDU behaviour the additional one. The Guide should be modified accordingly

PMTCT:

• A collaborative process was applied to produce the guide, involving many actors – UN agencies, NGOs etc. The guideline has reached its final stage and needs endorsement.

• There are six core indicators: two are UNGASS indicators, and four are additional indicators.

• Reference to “blood safety” issue should be made in the guideline.

• There was a discussion on the need for an indicator relating to capacity to implement (percent of health care workers trained in PMTCT, and country relevance)

• Measuring the “cascade” of service utilization was considered critical, i.e. # pregnant women--# pregnant women attending ANC--# of pregnant women counselled--# pregnant women who agree to HIV testing--# pregnant women who return for test results--# pregnant women who receive ARV’s--# infants who receive ARVs.

General observation:

• Substantial time was devoted to develop the guidelines.

• The guidelines should be disseminated as soon as possible in order to tap into the momentum. A framework or umbrella introduction should be developed to clarify for nNational programmes how the various guides should be used and should complement each other.

• Attempts should be made to avoid overlap with other guidelines, and to make the guidelines as user-friendly as possible for professionals at country-level.

• It is essential that parallel M&E systems are not established. Every opportunity for consolidating indicators into single measurement tools should be explored.

3.2. Working groups

The main task for the working groups was to discuss the roll out strategy for the guidelines. Summaries submitted by the rapporteurs are available in Annex 13 (Care and Support summary is to be received).

Young people:

• The guide is a useful advocacy tool.

• Most indicators have been widely field-tested; hence, further field-testing is not necessary.

• The number of indicators should be reduced.

• Clarification is needed with regards to cross-references to other guidelines.

• There is a need to better disaggregate young people in prevention messages - the 10-14 age-group should be removed from the core text as this target group requires special attention.

• The IDU guideindicators will be revisited by a full-time consultant to be hired to finalise the draft (Measure).

PMTCT:

• The title should remain as is “Guide for preventing the transmission to infants and young children”

• Indicator on “percent of health care workers trained in PMTCT” should not be applied to all countries.

• Indicator number four is to be finalised.

• The guide should mention that blood safety indicators can be found in the UNAIDS National AIDS Program M&E guide.

• WHO is responsible for finalizing the guide.

Care and Support:

• Reconsider human capacity indicators - consider naming “care and treatment” instead of “care and support”.

• There is a need to further field-test the indicators.

• There is a lack of focus on the private sector.

• More detail is needed in the tables and templates.

General comments:

• With regards to AIDS surveys (as part of DHS for example) the idea is to reduce and streamline data collection efforts.

• Inquiry should be made about lessons learnt from the use of the UNAIDS National AIDS Program M&E guide when further developing the guidelines.

• There is a need to explore how to best maximise the use and utility of the guidelines.

3.3. UNGASS Country reports

• There is a need to explore how to best encourage various sectors to work together on M&E activities in countries that do not have National AIDS Councils.

• It needs to be determined how to best strengthen UN capacity at country level to facilitate UNGASS reporting.

• There is a need to develop a strategy that would help sustain the UNGASS process.

• The guide on the construction of UNGASS DoC indicators should be further adapted to take into account lessons learned with each indicator. A plan of for future revisions should be presented at the next MERG meeting

3.4. Survey on coverage rates for essential services:

Preliminary results of the AIDS Program Index (API) second round

• A meeting will be held with national professionals from 41 priority countries to build consensus around the collected API data.

• All stakeholders will review data collected through the API and verify/provide estimates for service coverage.

• An IDU reference group and database may assist in the estimation of population sizes.

3.5. Global AIDS M&E Support Team (GAMET)

• GAMET has created an advisory board composed of cosponsors and bilateral agencies.

• The main role of GAMET is to assist “in-country” M&E coordination and provide technical assistance through a network of consultants (Mobile Support Team) with National AIDS Councils as principal partners. The use of the Mobile Support Teams is seen as an interim solution, and GAMET will explore for the longer term ways to strengthen institutional capacity

• Currently, 22 countries are covered (mainly MAP countries; only two are non-MAP countries).

• GAMET facilitates and co-funds also other M&E activities.

• GAMET’s emphasis is on brokering rather than direct provision of technical assistance, with the long term goal of National AIDS Councils coordinating access to technical resources

3.6. Global Fund to fight AIDS, TB, and Malaria (GFATM)

• Additional funds through the GFATM are available to strengthen existing M&E systems.

• GFATM works with networks of partners to reach objectives. For example, GFATM does not lead any indicator development exercise, but counts on its partners to provide standardised indicator sets.

• Disbursements based on results: For the first 24 months, focus was will be on obtaining results on process indicators; later, the focus was will be on coverage and impact indicators. Reporting will probably take place twice-a-year.

• The CCM advises the GFATM on disbursement of funds while the GFATM makes the final decision.

• GFATM would like to play a leading role in reaching consensus on one M&E system (one set of national indicators and one reporting system agreed upon by all actors).

• GFATM strongly endorses M&E – it recommends that five to seven percent of a programme/project budget be assigned to M&E.

• GFATM supports the idea to expand capacities of “untraditional entities” at country level such as faith-based organizations and the direct transfer of funds to these entities.

3.7. Country Response Information System (CRIS)

There will be an effort to document lessons learned from the CRIS/EVA training workshops, as well as to identify further how CRIS will be able to complement collaborate with other existing databases such as Child/Dev-Info. Achievements since 6th MERG Meeting:

• CRIS Version 1.4b (IND) has been released globally.

• Over 60 countries in four regions have been trained.

• Programming of Project / resource tracking & Research Inventory databases progressing.

• Many countries have established M&E working groups.

• Installation and use of CRIS has commenced in many countries.

• Global CRIS network has been established, including CRIS focal points within cosponsors.

Challenges that remain:

• Improved understanding of CRIS and its relationship with other information systems at the global, regional and national levels.

• National capacity for data collection and analysis leading to improved management of national responses.

• Data collection of indicators – priority.

• Resources – hardware and human capacity.

•

3.8. Estimates/Modelling

• It is difficult to compare current estimates with previous due to application of different methodologies – it is only possible to give indication of direction of trends, up or down.

•

• Training in these tools has been provided to 132 countries

• Collaborating partners include the US Centers for Disease Control and Prevention, Family Health International, UNICEF, WHO headquarters, and WHO Regional Offices.

• This training should result in better estimates and is helping to build capacity in countries.

(Isn’t there a little more here that we could get from Karen for this section?)

3.9. UN System Strategic Plan (UNSSP)

• The mid-term performance report will be submitted to the UNAIDS PCB in June 2004.

• The MERG will be kept informed on progress in mid-term performance of United Nations System Strategic Plan 2001-2005.

4. New M&E challenges

4.1. Issues specific to the current and evolving role of the MERG specific

• There is a need to further clarify the role of the MERG with regards to harmonization of instruments, consensus on new indicators, prioritization of research agenda, and most importantly how can the MERG contribute to capacity building/TA coordination at the country program level.etc.

• There is a need to establish sub-Committees in order to focus the work of the MERG, especially in areas such as: technical issues; training, harmonization; and capacity development.

• Composition of the MERG: adequate geographic and thematic representation should be ensured.

• Authority of the body: it needs to be determined if the MERG is an information sharing forum or a framework where actionable items are identified and addressed. points are identified.

• The relationship between the MERG and GAMET needs to be further clarified. It was proposed that GAMET should be considered on of the “implementation arms” of the MERG.

4.2. General

• Within the context of scaling-up: there is a need to respond to an increasing demand for strategic information to be used in planning, programming and research.

• Different types of information needs adds to the complexity of the issue: information that permits assessment if of programmes performance is according to plans (monitoring data); information that permits assessment of whether programmes are making a difference (programme evaluation data); and, information on best models for implementation (operations research).

• Information to assist in the refinement of program activities can be very different from information that is used for accountability to stakeholders.

• At this stage, emphasis is has on developing data collection methods (indicators, survey instruments etc.,) and less on implementation.

• With regards to the status of health information systems, tThere is a critical need to build monitoring systems and conduct a global coverage survey of key informants (2003) and a global district access/coverage survey with a focus on health systems (2004). (Not sure what this last one means???)

• There is a need to rethink some measurement issues, mainly second generation surveillance and self-reported risk behaviour in household surveys.

• A greater focus on evaluation is needed in order to be able to scale-up, measure impact, and plan well.

• Surveillance should be conceptually integrated with M&E activities.

• Coordination at both global and country levels should be improved.

• Stronger evaluation efforts should be made in the area of impact of Behavioural Change programs.

• Decentralisation of M&E activities need to take into consideration the differing data needs at local and national levels, and sensitisation and skills building is needed at local level.

• Guidelines are also needed for district level use.

4.3. Immediate Actionable Items

:

• UNAIDS will review the TOR for the MERG and incorporate the comments that were provided during this meeting

• Subgroups will be established based on perceived needs. Two examples of possible subgroups are: Training Harmonization and Coordination Group” and the “Rapid Intervention Technical Group.”

• The three indicator guideline documents are endorsed for dissemination, with the suggested revisions as noted above.

• The MERG will work with key members to develop a concise “umbrella” document that briefly summarizes the different multiple indicator guidelines, discusses key principles for indicator selection, and provides illustrative models where indicators from these different thematic areas can be consolidated into single surveillance activities. This will be disseminated along with the new indicator guidelines before the end of the calendar year

• The next MERG meeting will be convened within the next 6 to 12 months.

Seventh Meeting of the UNAIDS Monitoring and Evaluation Reference Group (MERG) – Geneva, Switzerland 28-29 July 2003

WHO, Room D

PROVISIONAL AGENDA

Day 1 – MONDAY, 28 JULY

8:30 – 9:00 Registration

9:00 – 9:30 Welcome and introduction Paul De Lay

Objectives of the Meeting

Adoption of the Agenda

9:30 –10:45 Indicator development

Chairs: Gabriel Mwaluko/Ties Boerma

Young People

Orphans (OVC)

Care & Support

IDU

PMTCT

Questions and answers

10:45 – 11:00 UNAIDS and the MERG Kathleen Cravero

11:00 - 11:15 COFFEE / TEA

11:15 – 12:15 Three working groups –one for each of the three available indicator guidelines (Care and Support, Young People, and PMTCT)

12:15 – 13:15 Presentation from each working group followed by plenary discussion

13:15 – 14:15 LUNCH

14:15-17:00 Developments in M&E of HIV/AIDS programs

Chairs: Yitades Gebre/Chika Saito

UNGASS country reports: Lessons learnt for Michel Caraël

M&E capacity building

Survey on coverage rates for essential services John Novak

Preliminary results of the API second round

New Challenges in M&E Ties Boerma

Presentations followed by plenary discussion

15:30 – 15:45 COFFEE / TEA

DAY 2 – TUESDAY, 29 JULY

09:00 – 12:00 Developments in global M&E initiatives

Chairs: Jacqueline Bataringaya/John Novak

09:00 –9:45 Global HIV/AIDS Monitoring and Evaluation Team (GAMET)

Update on GAMET David Wilson Plenary discussion

9:45–10:00 COFFEE / TEA

10:00 – 10:30 Preliminary Update on M&E activities Bernhard Schwartlander in the new WHO

10:30 – 11:15 Update on the Global Fund M&E strategy Brad Herbert

11:15-12:00 Country Response Information System (CRIS)

Update on the CRIS Geoff Manthey

Plenary discussion

12:00-12:30 Surveillance, Estimates and Projections, latest update Karen Stanecki

12:30 –14:00 LUNCH

14:00 –14:15 UNSSP mid-term evaluation

Presentation of the upcoming UNSSP evaluation Reeta Bhatia

14:15 – 15:15 M&E at the Global and Country Levels

Scope of Work and Composition of the MERG Paul De Lay

Plenary discussion

15:15 –15:30 COFFEE / TEA

15:30 – 16:00 The way forward Paul De Lay

Closure and next steps

MONITORING AND EVALUATION REFERENCE GROUP (MERG)

7th MERG Meeting in Geneva, Switzerland (WHO-Room D) on 28-29 July 2003

PROVISIONAL LIST OF PARTICIPANTS

|Name |Contact details |Organization/Country |

| |

|NATIONAL GOVERNMENTS |

|1. Yitades GEBRE |National HIV/AIDS Prevention and Control Program |MoH |Jamaica |

| |Ministry of Health | | |

| |2-4 King Street, | | |

| |Kingston, Jamaica | | |

| |Tel: +876 922 2448 | | |

| |Fax: +876 967 1643 | | |

| |E-mail: gebrey@.jm | | |

| |

|BILATERAL AGENCIES/NATIONAL GOVERNMENT AGENCIES/ |

|US FUNDED PROJECTS |

| 2. John NOVAK |United States Agency for International Development |USAID |USA |

| |5th Floor RRB | | |

| |1300 Pennsylvania Avenue N.W. | | |

| |Washington, D.C. 20523-3700, USA | | |

| |Tel: +1 202 712 4814 | | |

| |Fax: +1 202 216 3046 | | |

| |E-mail: jnovak@ | | |

| | | | |

|3. Deborah RUGG |Global AIDS Program |CDC |USA |

| |Centers for Disease Control and Prevention | | |

| |1600 Clifton Road. Mailstop E41 | | |

| |Atlanta, GA 30333 | | |

| |USA | | |

| |Tel: +1 404 498 2790 | | |

| |Fax: +1 404 498 2785 | | |

| |E-mail: dlr3@ | | |

| | | | |

|4. Erin ECKERT |ORC/Macro (Measure Evaluation) |ORC/Macro |USA |

| |11785 Beltsville Drive, Ste. 300 | | |

| |Calverton | | |

| |Maryland 20703 | | |

| |USA | | |

| |Tel: +1 301 572 0397 | | |

| |Fax: +1 301 572 0999 | | |

| |E-mail: Erin.L.Eckert@ | | |

|5. Bernard BARRERE |Measure Demographic Health Survey |Measure DHS+ |USA |

| |ORC Macro |ORC MACRO | |

| |11785 Beltsville Drive, Calverton | | |

| |Maryland 20705 | | |

| |USA | | |

| |Tel: +1 301 572 0957 | | |

| |Fax: +1 302 572 0999 | | |

| |E-mail: bernard.barrere@ | | |

|6. Joshua VOLLE |Family Health International |FHI |USA |

| |Evaluation, Surveillance and Research | | |

| |2101 Wilson Boulevard, Suite 700 | | |

| |Arlington, VA 22201 | | |

| |USA | | |

| |Tel: +1 703 516 9779 | | |

| |Fax: +1 703 516 9781 | | |

| |E-mail: jvolle@ | | |

| |

|ACADEMIC/RESEARCH INSTITUTES |

|7. Nicolas MEDA |Centre MURAZ |Centre MURAZ |Burkina Faso |

| |Ministry of Health Biomedical | | |

| |Research and Training Institute | | |

| |PO Box 390 | | |

| |Bobo-Dioulasso 01 | | |

| |Burkina Faso | | |

| |Tel: +226 97 26 30 | | |

| |Fax: +226 97 01 77 | | |

| |E-mail: nmeda.muraz@fasonet.bf | | |

| |medaxel@ | | |

|8. John CLELAND |Centre for Population Studies |LSHTM |UK |

| |London School of Hygiene and | | |

| |Tropical Medicine | | |

| |49-51 Bedford Square | | |

| |London WC1B 3DP | | |

| |Tel: +44 207 299 4621 | | |

| |Fax: +44 207 299 4637 | | |

| |E-mail: john.cleland@lshtm.ac.uk | | |

| |

|COSPONSORS |

|9. Roeland MONASCH |Statistics and Monitoring |UNICEF |

| |United Nations Children’s Fund | |

| |R-492 3 United Nations Plaza | |

| |New York, NY 10017 | |

| |USA | |

| |Tel: +1 212 303 7982 | |

| |Fax: +1 212 824 6490 | |

| |E-mail: rmonasch@ | |

|10. Mary MAHY |Division of Policy and Planning |UNICEF |

| |United Nations Children’s Fund | |

| |H-4A, 3 United Nations Plaza | |

| |New York, NY 10017 | |

| |USA | |

| |Tel: +1 212 327 7247 | |

| |Fax: +1 212 824 6490 | |

| |E-mail: mmahy@ | |

|11. Joseph ANNAN |Evaluation Office |UNDP |

| |United Nations Development Programme | |

| |1 United Nations Plaza DC1-462 | |

| |New York, NY 10017 | |

| |USA | |

| |Tel: +1 212 906 5074 | |

| |Fax: +1 212 906 5023 | |

| |E-mail: joseph.annan@ | |

|12. Chika SAITO |HIV/AIDS and Development |UNDP |

| |United Nations Development Programme | |

| |1 United Nations Plaza DC1-462 | |

| |New York, NY 10017 | |

| |USA | |

| |Tel: + 1 212 906 5014 | |

| |Fax: +1 212 906 5023 | |

| |E-mail: chika.saito@ | |

|13. Bongs LAINJO |Office of Oversight and Evaluation |UNFPA |

| |United Nations Population Fund | |

| |220 East 42nd Street | |

| |New York, NY 10017 | |

| |USA | |

| |Tel: +1 212 297 5229 | |

| |Fax: +1 212 297 4938 | |

| |E-mail : lainjo@ | |

|14. Benjamin ALLI |Technical Cooperation |ILO |

| |International Labour Office | |

| |4, route des Morillons | |

| |CH-1211 Geneva 22 | |

| |Tel: +4122 799 6438 | |

| |Fax: +4122 799 6668 | |

| |Email: alli@ | |

| | | |

|15. Geoffrey GEURTS |Internal Oversight Service |UNESCO |

| |United Nations Educational, Scientific and Cultural | |

| |Organization | |

| |7 place de Fontenoy | |

| |75352 Paris | |

| |France | |

| |Tel: +33 1 45 68 1236 | |

| |Fax: +33 1 45 68 5571 | |

| |E-mail: g.geurts@ | |

|16. Ties BOERMA |Surveillance, Monitoring & Research Evaluation Team |WHO |

| |Department of HIV/AIDS | |

| |World Health Organisation | |

| |20 Avenue Appia | |

| |CH-1211 Geneva 27, Switzerland | |

| |Tel: +41 22 791 1481 | |

| |Fax: +41 22 791 4834 | |

| |E-mail: boermat@who.int | |

|17. J.M Garcia CALLEJA |FCH/HIV/SMR |WHO |

| |Surveillance, Monitoring and Research | |

| |Evaluation Team | |

| |World Health Organisation | |

| |20 Avenue Appia | |

| |CH-1211 Geneva 27, Switzerland | |

| |Tel: +41 22 791 4252 | |

| |Fax: +41 22 791 4834 | |

| |E-mail: callejaj@who.int | |

|18. Kevin O'REILLY |Surveillance, Research, Monitoring & Evaluation Team |WHO |

| |Department of HIV/AIDS | |

| |World Health Organisation | |

| |20 Avenue Appia | |

| |CH-1211 Geneva 27, Switzerland | |

| |Tel: +41 22 791 4507 | |

| |Fax: +41 22 791 4834 | |

| |E-mail: oreillyk@who.int | |

| | | |

|19. Bernhard SCHWARTLANDER |Family and Community Health |WHO |

| |Department of HIV/AIDS | |

| |World Health Organisation | |

| |20 Avenue Appia | |

| |CH-1211 Geneva 27, Switzerland | |

| |Tel: +41 22 791 4705 | |

| |Fax: +41 22 791 4834 | |

| |E-mail: schwartlanderb@who.int | |

| | | |

|20. David WILSON |Monitoring and Evaluation |World Bank |

| |Support Team | |

| |Global HIV/AIDS Office | |

| |The World Bank | |

| |1818 H. Street, N.W. | |

| |Washington D.C. 20433 | |

| |USA | |

| |Tel: +1 202 458 2537 | |

| |Fax: +1 202 522 7396 | |

| |E-mail: dwilson@ | |

| |Dwilson@ | |

| | | |

| |

|NON GOVERNMENTAL ORGANIZATIONS |

|21. Jacqueline BATARINGAYA |ActionAid Africa |ActionAid |Zimbabwe |

| |Regional Office |International | |

| |16 York Avenue | | |

| |Newlands | | |

| |Harare | | |

| |Zimbabwe | | |

| |Tel: +263 4 788122/3 | | |

| |Fax: +263 4 788 124 | | |

| |E-mail: bataringayaj@.zw | | |

| | | | |

|22. Gabriel MWALUKO |Tanzania-Netherlands project to support AIDS control |TANESA |Tanzania |

| |in Mwanza Region | | |

| |P O Box 434 | | |

| |MWANZA, Tanzania | | |

| |Tel: +255 282 500236 | | |

| |Fax : +255 282 502458 | | |

| |Mobile: +255 (0) 744 274545 | | |

| |E-mail : | | |

| |gmwaluko@mwanza- | | |

| | | | |

| | | | |

| |

|GLOBAL FUND SECRETARIAT |

|23. Brad HERBERT |Global Fund to Fight AIDS, Tuberculosis and Malaria |GFATM |Switzerland |

| |53, Avenue Louis-Casaï | | |

| |1216 Geneva-Cointrin, Switzerland | | |

| |Tel: +41 22 791 17 12 | | |

| |Fax: +41 22 791 17 01 | | |

| |E-mail: Brad.Herbert@ | | |

| | | | |

| |

|UNAIDS SECRETARIAT |

|24. Kathleen CRAVERO |Executive Office |UNAIDS |

| |UNAIDS | |

| |20 avenue Appia | |

| |CH – 1211 Geneva 27 | |

| |Tel: +41 22 791 4716 | |

| |Fax: +41 22 791 4187 | |

| |E-mail: craverok@ | |

|25. Paul DE LAY |Monitoring & Evaluation Team |UNAIDS |

| |UNAIDS | |

| |20 avenue Appia | |

| |CH – 1211 Geneva 27 | |

| |Tel: +41 22 791 4534 | |

| |Fax: +41 22 791 4768 | |

| |E-mail: delayp@ | |

|26. Michel CARAEL |Monitoring & Evaluation Team |UNAIDS |

| |UNAIDS | |

| |20 avenue Appia | |

| |CH – 1211 Geneva 27 | |

| |Tel: +41 22 791 4651 | |

| |Fax: +41 22 791 4768 | |

| |E-mail: caraelm@ | |

| | | |

|27. Nicole MASSOUD |Monitoring & Evaluation Team |UNAIDS |

| |UNAIDS | |

| |20 avenue Appia | |

| |CH – 1211 Geneva 27 | |

| |Tel: +41 22 791 4694 | |

| |Fax: +4122 791 4768 | |

| |E-mail: massoudn@ | |

|28. Soichi KOIKE |Monitoring & Evaluation Team |UNAIDS |

| |UNAIDS | |

| |20 avenue Appia | |

| |CH – 1211 Geneva 27 | |

| |Tel: +41 22 791 1502 | |

| |Fax: +4122 791 4768 | |

| |E-mail: koikes@ | |

|29. Zero AKYOL |Monitoring & Evaluation Team |UNAIDS |

| |UNAIDS | |

| |20 avenue Appia | |

| |CH – 1211 Geneva 27 | |

| |Tel: +41 22 791 2522 | |

| |Fax: +4122 791 4768 | |

| |E-mail: akyolz@ | |

|30. Louise BERRY |Monitoring & Evaluation Team |UNAIDS |

| |UNAIDS | |

| |20 avenue Appia | |

| |CH – 1211 Geneva 27 | |

| |Tel: +41 22 791 4915 | |

| |Fax: +4122 791 4768 | |

| |E-mail: berryl@ | |

|31. Geoff MANTHEY |Monitoring & Evaluation Team (CRIS) |UNAIDS |

| |UNAIDS | |

| |20 avenue Appia | |

| |CH – 1211 Geneva 27 | |

| |Tel: +41 22 791 1373 | |

| |Fax: +4122 791 4188 | |

| |E-mail: mantheyg@ | |

|32. Patrick WHITAKER |Monitoring & Evaluation Team |UNAIDS |

| |(CRIS) | |

| |UNAIDS | |

| |20 avenue Appia | |

| |CH – 1211 Geneva 27 | |

| |Tel: +41 22 791 1372 | |

| |Fax: +4122 791 4188 | |

| |E-mail: whitakerp@ | |

|33. Karianne BYE |Monitoring & Evaluation Team |UNAIDS |

| |(CRIS) | |

| |UNAIDS | |

| |20 avenue Appia | |

| |CH – 1211 Geneva 27 | |

| |Tel: +41 22 791 1359 | |

| |Fax: +4122 791 4188 | |

| |E-mail: byek@ | |

|34. Catherine HANKINS |Strategic Information |UNAIDS |

| |UNAIDS | |

| |20 avenue Appia | |

| |CH – 1211 Geneva 27 | |

| |Tel: +41 22 791 3865 | |

| |Fax: +4122 791 4898 | |

| |E-mail: hankinsc@ | |

|35. Karen STANECKI |Epidemic & Impact Monitoring Team |UNAIDS |

| |UNAIDS | |

| |20 avenue Appia | |

| |CH – 1211 Geneva 27 | |

| |Tel: +41 22 791 1662 | |

| |Fax: +4122 791 4898 | |

| |E-mail: staneckik@ | |

|36. Reeta BHATIA |UN System Programme Review |UNAIDS |

| |UNAIDS | |

| |20 avenue Appia | |

| |CH – 1211 Geneva 27 | |

| |Tel: +41 22 791 1371 | |

| |Fax: +4122 791 4768 | |

| |E-mail: bhatiar@ | |

|37. Karl-Lorenz Dehne |Dr Karl-Lorenz Dehne |UNAIDS |

| |UNAIDS | |

| |Vienna International Center, Room D1470 | |

| |Wagramer Strasse 5, | |

| |A-1400 Vienna, Austria | |

| |Tel: +43 1 26060 4662 | |

| |Fax: +43 1 26060 7549 | |

| |E-mail: | |

| |Karl-Lorenz.Dehne@ | |

ANNEX 1

3

Working Groups on indicators, summaries submitted by rapporteurs..

A. Summary of sub-group meeting Working Group on Young People indicators

Submitted by Rapporteur: Cyril Pervilhac, WHO

1. The working group on Young People confirmed the need for such a guide as an important advocacy tool to complement other Guides and recommends for this reason to carefully cross- reference other materials (e.g. indicators) used.

2. The 21 “core” indicators identified, among a total 37 indicators, have largely the ones which are currently being used and have been validated and do not need any field testing. The list of indicators needs to be reduced among all types of indicators (e.g. MTCT has 6 core, and OVC has 10). There are too many “Health Service Indicators” and the most important ones need to be identified and combined.

3. The working group suggests not to include the 10-14 years old indicators. This delicate decision was queried and discussed, and agreed upon in plenary. The group acknowledged that the 10-14 years old group is recognised to be an important intervention group. This age groupey are is currently covered by the MGD/ UNGASS indicators on life skills/ trained teachers and were therefore included in the draft Guide, and the Guide will include those related to life skills.

The group recognises the importance of issues like connectedness and regulations, yet, it is not clear how the information collected informs future programmes for action, nor is it clear if tools work in developing country settings (in contrast to the recent experience gathered in a few industrialised countries). These types of indicators, in consequence, need further research and field testing and cannot at this stage be broadly recommended to NAPs, in comparison to the other indicators. In addition, MACRO recommend the use of special surveys (quantitative and qualitative mix with parent’s or schools consent) to work with this age group as per the present experience in four4 countries in Sub-Saharan Africa. with the Allan Guttmacher Institute. A special section in the Guide can recommend and refer to recommended indicators (e.g. p. 2 nb 5 to 8 of Table on Indicators).

4. The essential tool used for Young People is Household surveys among 15-24, and this needs to be made clear in the Guide. In some cases school surveys and surveys of children in institutions (small proportion) can be used. School sampling should not be part of the Guide but can be referred to.

5. Indicators on IDU in young people will be further refined with indicators 12, 13, 14 to be replaced by UNGASS IDU indicators (Karl Dehne’s inputs).

6. Rolling out: Measure/ Evaluation will identify and support a full-time consultant to revisit the draft in September to mid-October. as per recommendations of the group. A desk review will be reviewed in the following month and a final document produced in December. The group recommends an “umbrella” document to serves as an introduction to all the Guides to facilitate the understanding how they complement each other.

B. Working group on PMTCT

Summary of sub-group meeting on PMTCT indicators

Submitted by Rapporteur: Mary Mahy, UNICEF

The five general points made from the group included the following:

1. The title would stay as “guide for preventing the transmission to infants and young children”. Even though this would seem to include blood based transmission this will be kept as is because research is still determining the proportion of infections through blood based transmission. Until the research has been concluded this is a major factor, no indicators on this will be included. In the meantime a note to this affect and stating that indicators for monitoring blood safety indicators could be found in the UNAIDS guide.

2. It was additionally emphasized that the title should not be preventing mother to child transmission because this did not adequately represent the broader reach of the intervention to achieve all four prongs instead of only prong 3.

3. There is still some discussion going on regarding whether core indicator 4 captures coverage adequately. It was pointed out that both indicators 3 and 5 capture coverage to some degree. [As of August 13, coverage is excluded from indicator 4.]

4. It was noted that there are efforts from the president’s initiative discussing how Health Management Information Systems can be used to better monitor PMTCT activities. This effort is still at an early stage. Until the system, is further developed, the current indicators and their suggested collection methods will be followed.

5. A number of additional small comments were made including that a paragraph should be included for indicator 2 that states that the proportion of health workers trained in PMTCT care should be judged based on the level of the epidemic in the community and should not necessarily by 100%. Also there were some editorial comments suggested. These were to be provided in hard copy to WHO.

The roles and responsibilities were determined to be as follows:

WHO will finish editing the guide and will make the above mentioned adjustments.

It was hoped that in September 2003, this would be completed for publication. This will change of course based on the decision to streamline the different guides.

C. Summary of sub-group meeting on Care and Support indicators

Submitted by Shanthi Noriega, WHO

The care and support working group acknowledged the importance of the care and support monitoring and evaluation guide. The current push to increase access to care and support for PLWHA makes this guide timely, and there is obvious need to provide national programmes with guidance.

In reviewing the current draft, the working group highlighted the following points:

• There is a need to reconsider human capacity indicators

• There is a need to further field-test the indicators.

• There is a lack of focus on the private sector.

• More detail is needed in the tables and templates.

Each of these points were addressed in turn.

The current manual contains ten core indicators covering a wide range of care and support needs. However, the MERG working group felt that human capacity indicators were missing and requested indicators related to this be considered. All members agreed that human capacity is an important issue to address, but given the need for further development, they would not be included in this version of the manual. The issue has been turned over to the manual’s drafting group, who will share this point with the larger care and support working group in order to guarantee that this issue is addressed at a later date.

Indicators presented in the guide have been field tested in Africa (Kenya and Ethiopia) and the Dominican Republic. It is acknowledged that further testing is required in different settings, and FHI shared plans to continue field testing indicators in selected Asian countries. The overall experience will feed into the adaptation of indicators and instruments as required.

Editorial issues related to the lack of emphasis on the private sector and additional detail for tables and templates were taken into account. It was clarified that the manual is intended for both public and private national programmes and this will be drawn out in the final draft of the document. The same decision was made regarding the need for more detail in tables and templates.

Overall, the working group felt that the manual represented a good effort in providing national care and support programmes with guidance on monitoring and evaluation. It was agreed that the manual would go to press with minor modifications, but that the larger issues related to additional indicators for human capacity would be acknowledged in this manual and efforts would be made to address this need in the near future.

ANNEX 2

Seventh Meeting of the UNAIDS Monitoring and Evaluation Reference Group (MERG) – Geneva, Switzerland 28-29 July 2003

WHO, Room D

PROVISIONAL AGENDA

Day 1 – MONDAY, 28 JULY

8:30 – 9:00 Registration

9:00 – 9:30 Welcome and introduction Paul De Lay

Objectives of the Meeting

Adoption of the Agenda

9:30 –10:45 Indicator development

Chairs: Gabriel Mwaluko/Ties Boerma

Young People

Orphans (OVC)

Care & Support

IDU

PMTCT

Questions and answers

10:45 – 11:00 UNAIDS and the MERG Kathleen Cravero

11:00 - 11:15 COFFEE / TEA

11:15 – 12:15 Three working groups –one for each of the three available indicator guidelines (Care and Support, Young People, and PMTCT)

12:15 – 13:15 Presentation from each working group followed by plenary discussion

13:15 – 14:15 LUNCH

14:15-17:00 Developments in M&E of HIV/AIDS programs

Chairs: Yitades Gebre/Chika Saito

UNGASS country reports: Lessons learnt for Michel Caraël

M&E capacity building

Survey on coverage rates for essential services John Novak

Preliminary results of the API second round

New Challenges in M&E Ties Boerma

Presentations followed by plenary discussion

15:30 – 15:45 COFFEE / TEA

DAY 2 – TUESDAY, 29 JULY

09:00 – 12:00 Developments in global M&E initiatives

Chair: John Novak

09:00 –9:45 Global HIV/AIDS Monitoring and Evaluation Team (GAMET)

Update on GAMET David Wilson Plenary discussion

9:45–10:00 COFFEE / TEA

10:00 – 10:30 Preliminary Update on M&E activities Bernhard Schwartlander in the new WHO

10:30 – 11:15 Update on the Global Fund M&E strategy Brad Herbert

11:15-12:00 Country Response Information System (CRIS)

Update on the CRIS Geoff Manthey

Plenary discussion

12:00-12:30 Surveillance, Estimates and Projections, latest update

Karen Stanecki

12:30 –14:00 LUNCH

14:00 –14:15 UNSSP mid-term evaluation

Presentation of the upcoming UNSSP evaluation Reeta Bhatia

14:15 – 15:15 M&E at the Global and Country Levels

Scope of Work and Composition of the MERG Paul De Lay

Plenary discussion

15:15 –15:30 COFFEE / TEA

15:30 – 16:00 The way forward Paul De Lay

Closure and next steps

ANNEX 3

MONITORING AND EVALUATION REFERENCE GROUP (MERG)

7th MERG Meeting in Geneva, Switzerland (WHO-Room D) on 28-29 July 2003

LIST OF ATTENDEES

|Name |Contact details |Organization/Country |

| |

|NATIONAL GOVERNMENTS |

|1. Yitades GEBRE |National HIV/AIDS Prevention and Control Program |MoH |Jamaica |

| |Ministry of Health | | |

| |2-4 King Street, | | |

| |Kingston, Jamaica | | |

| |Tel: +876 922 2448 | | |

| |Fax: +876 967 1643 | | |

| |E-mail: gebrey@.jm | | |

| | | | |

| |

|BILATERAL AGENCIES/NATIONAL GOVERNMENT AGENCIES/ |

|US FUNDED PROJECTS |

| 2. John NOVAK |United States Agency for International Development |USAID |USA |

| |5th Floor RRB | | |

| |1300 Pennsylvania Avenue N.W. | | |

| |Washington, D.C. 20523-3700, USA | | |

| |Tel: +1 202 712 4814 | | |

| |Fax: +1 202 216 3046 | | |

| |E-mail: jnovak@ | | |

| | | | |

| | | | |

|3. Deborah RUGG |Global AIDS Program |CDC |USA |

| |Centers for Disease Control and Prevention | | |

| |1600 Clifton Road. Mailstop E41 | | |

| |Atlanta, GA 30333 | | |

| |USA | | |

| |Tel: +1 404 498 2796 | | |

| |Fax: +1 404 498 2785 | | |

| |E-mail: drugg@ | | |

| | | | |

| | | | |

|4. Erin ECKERT |ORC/Macro (Measure Evaluation) |ORC/Macro |USA |

| |11785 Beltsville Drive, Ste. 300 | | |

| |Calverton | | |

| |Maryland 20703 | | |

| |USA | | |

| |Tel: +1 301 572 0397 | | |

| |Fax: +1 301 572 0999 | | |

| |E-mail: Erin.L.Eckert@ | | |

|5. Bernard BARRERE |Measure Demographic Health Survey |Measure DHS+ |USA |

| |ORC Macro |ORC MACRO | |

| |11785 Beltsville Drive, Calverton | | |

| |Maryland 20705 | | |

| |USA | | |

| |Tel: +1 301 572 0957 | | |

| |Fax: +1 302 572 0999 | | |

| |E-mail: bernard.barrere@ | | |

|6. Joshua VOLLE |Family Health International |FHI |USA |

| |Evaluation, Surveillance and Research | | |

| |2101 Wilson Boulevard, Suite 700 | | |

| |Arlington, VA 22201 | | |

| |USA | | |

| |Tel: +1 703 516 9779 | | |

| |Fax: +1 703 516 9781 | | |

| |E-mail: jvolle@ | | |

| |

|ACADEMIC/RESEARCH INSTITUTES |

|7. Nicolas MEDA |Centre MURAZ |Centre MURAZ |Burkina Faso |

| |Ministry of Health Biomedical | | |

| |Research and Training Institute | | |

| |PO Box 390 | | |

| |Bobo-Dioulasso 01 | | |

| |Burkina Faso | | |

| |Tel: +226 97 26 30 | | |

| |Fax: +226 97 01 77 | | |

| |E-mail: nmeda.muraz@fasonet.bf | | |

| |medaxel@ | | |

|8. John CLELAND |Centre for Population Studies |LSHTM |UK |

| |London School of Hygiene and | | |

| |Tropical Medicine | | |

| |49-51 Bedford Square | | |

| |London WC1B 3DP | | |

| |Tel: +44 207 299 4621 | | |

| |Fax: +44 207 299 4637 | | |

| |E-mail: john.cleland@lshtm.ac.uk | | |

| |

|COSPONSORS |

|9. Roeland MONASCH |Statistics and Monitoring |UNICEF |

| |United Nations Children’s Fund | |

| |R-492 3 United Nations Plaza | |

| |New York, NY 10017 | |

| |USA | |

| |Tel: +1 212 303 7982 | |

| |Fax: +1 212 824 6490 | |

| |E-mail: rmonasch@ | |

|10. Mary MAHY |Division of Policy and Planning |UNICEF |

| |United Nations Children’s Fund | |

| |H-4A, 3 United Nations Plaza | |

| |New York, NY 10017 | |

| |USA | |

| |Tel: +1 212 327 7247 | |

| |Fax: +1 212 824 6490 | |

| |E-mail: mmahy@ | |

|11. Joseph ANNAN |HIV/AIDS Group |UNDP |

| |Bureau for Development Policy | |

| |United Nations Development Programme | |

| |1 United Nations Plaza DC1-462 | |

| |New York, NY 10017 | |

| |USA | |

| |Tel: +1 212 906 5074 | |

| |Fax: +1 212 906 5023 | |

| |E-mail: joseph.annan@ | |

|12. Chika SAITO |HIV/AIDS Group |UNDP |

| |Bureau for Development Policy | |

| |United Nations Development Programme | |

| |1 United Nations Plaza DC1-462 | |

| |New York, NY 10017 | |

| |USA | |

| |Tel: + 1 212 906 5014 | |

| |Fax: +1 212 906 5023 | |

| |E-mail: chika.saito@ | |

| | | |

| | | |

|13. Bongs LAINJO |Office of Oversight and Evaluation |UNFPA |

| |United Nations Population Fund | |

| |220 East 42nd Street | |

| |New York, NY 10017 | |

| |USA | |

| |Tel: +1 212 297 5229 | |

| |Fax: +1 212 297 4938 | |

| |E-mail : lainjo@ | |

| | | |

| | | |

|14. Pallavi RAI |Technical Cooperation |ILO |

| |International Labour Office | |

| |4, route des Morillons | |

| |CH-1211 Geneva 22 | |

| |Tel: +4122 799 6438 | |

| |Fax: +4122 799 6668 | |

| |Email: rai@ | |

| | | |

|15. Geoffrey GEURTS |Internal Oversight Service |UNESCO |

| |United Nations Educational, Scientific and Cultural | |

| |Organization | |

| |7 place de Fontenoy | |

| |75352 Paris | |

| |France | |

| |Tel: +33 1 45 68 1236 | |

| |Fax: +33 1 45 68 5571 | |

| |E-mail: g.geurts@ | |

|16. Ties BOERMA |Surveillance, Monitoring & Research Evaluation Team |WHO |

| |Department of HIV/AIDS | |

| |World Health Organisation | |

| |20 Avenue Appia | |

| |CH-1211 Geneva 27, Switzerland | |

| |Tel: +41 22 791 1481 | |

| |Fax: +41 22 791 4834 | |

| |E-mail: boermat@who.int | |

|17. J.M Garcia CALLEJA |FCH/HIV/SMR |WHO |

| |Surveillance, Monitoring and Research | |

| |Evaluation Team | |

| |World Health Organisation | |

| |20 Avenue Appia | |

| |CH-1211 Geneva 27, Switzerland | |

| |Tel: +41 22 791 4252 | |

| |Fax: +41 22 791 4834 | |

| |E-mail: callejaj@who.int | |

| | | |

|18. Cyril PERVILHAC |Surveillance, Research, Monitoring & Evaluation Team |WHO |

| |Department of HIV/AIDS | |

| |World Health Organisation | |

| |20 Avenue Appia | |

| |CH-1211 Geneva 27, Switzerland | |

| |Tel: +41 22 791 1323 | |

| |Fax: +41 22 791 4834 | |

| |E-mail: pervilhacc@who.int | |

|19. Kevin O'REILLY |Surveillance, Research, Monitoring & Evaluation Team |WHO |

| |Department of HIV/AIDS | |

| |World Health Organisation | |

| |20 Avenue Appia | |

| |CH-1211 Geneva 27, Switzerland | |

| |Tel: +41 22 791 4507 | |

| |Fax: +41 22 791 4834 | |

| |E-mail: oreillyk@who.int | |

| | | |

|20. Bernhard SCHWARTLANDER |Family and Community Health |WHO |

| |Department of HIV/AIDS | |

| |World Health Organisation | |

| |20 Avenue Appia | |

| |CH-1211 Geneva 27, Switzerland | |

| |Tel: +41 22 791 4705 | |

| |Fax: +41 22 791 4834 | |

| |E-mail: schwartlanderb@who.int | |

| | | |

| | | |

| | | |

|21. David WILSON |Monitoring and Evaluation |World Bank |

| |Support Team | |

| |Global HIV/AIDS Office | |

| |The World Bank | |

| |1818 H. Street, N.W. | |

| |Washington D.C. 20433 | |

| |USA | |

| |Tel: +1 202 458 2537 | |

| |Fax: +1 202 522 7396 | |

| |E-mail: dwilson@ | |

| |Dwilson@ | |

| | | |

| | | |

| |

|NON GOVERNMENTAL ORGANIZATIONS |

|22. Gabriel MWALUKO |Tanzania-Netherlands project to support AIDS control |TANESA |Tanzania |

| |in Mwanza Region | | |

| |P O Box 434 | | |

| |MWANZA, Tanzania | | |

| |Tel: +255 282 500236 | | |

| |Fax : +255 282 502458 | | |

| |Mobile: +255 (0) 744 274545 | | |

| |E-mail : | | |

| |gmwaluko@mwanza- | | |

| | | | |

| | | | |

| |

|GLOBAL FUND SECRETARIAT |

|23. Brad HERBERT |Global Fund to Fight AIDS, Tuberculosis and Malaria |GFATM |Switzerland |

| |53, Avenue Louis-Casaï | | |

| |1216 Geneva-Cointrin, Switzerland | | |

| |Tel: +41 22 791 17 12 | | |

| |Fax: +41 22 791 17 01 | | |

| |E-mail: Brad.Herbert@ | | |

| | | | |

| | | | |

| |

|UNAIDS SECRETARIAT |

|24. Kathleen CRAVERO |Executive Office |UNAIDS |

| |UNAIDS | |

| |20 avenue Appia | |

| |CH – 1211 Geneva 27 | |

| |Tel: +41 22 791 4716 | |

| |Fax: +41 22 791 4187 | |

| |E-mail: craverok@ | |

| | | |

| | | |

|25. Paul DE LAY |Monitoring & Evaluation Team |UNAIDS |

| |UNAIDS | |

| |20 avenue Appia | |

| |CH – 1211 Geneva 27 | |

| |Tel: +41 22 791 4534 | |

| |Fax: +41 22 791 4768 | |

| |E-mail: delayp@ | |

|26. Michel CARAEL |Monitoring & Evaluation Team |UNAIDS |

| |UNAIDS | |

| |20 avenue Appia | |

| |CH – 1211 Geneva 27 | |

| |Tel: +41 22 791 4651 | |

| |Fax: +41 22 791 4768 | |

| |E-mail: caraelm@ | |

| | | |

| | | |

|27. Nicole MASSOUD |Monitoring & Evaluation Team |UNAIDS |

| |UNAIDS | |

| |20 avenue Appia | |

| |CH – 1211 Geneva 27 | |

| |Tel: +41 22 791 4694 | |

| |Fax: +4122 791 4768 | |

| |E-mail: massoudn@ | |

|28. Soichi KOIKE |Monitoring & Evaluation Team |UNAIDS |

| |UNAIDS | |

| |20 avenue Appia | |

| |CH – 1211 Geneva 27 | |

| |Tel: +41 22 791 1502 | |

| |Fax: +4122 791 4768 | |

| |E-mail: koikes@ | |

|29. Zero AKYOL |Monitoring & Evaluation Team |UNAIDS |

| |UNAIDS | |

| |20 avenue Appia | |

| |CH – 1211 Geneva 27 | |

| |Tel: +41 22 791 2522 | |

| |Fax: +4122 791 4768 | |

| |E-mail: akyolz@ | |

|30. Louise BERRY |Monitoring & Evaluation Team |UNAIDS |

| |UNAIDS | |

| |20 avenue Appia | |

| |CH – 1211 Geneva 27 | |

| |Tel: +41 22 791 4915 | |

| |Fax: +4122 791 4768 | |

| |E-mail: berryl@ | |

|31. Geoff MANTHEY |Monitoring & Evaluation Team (CRIS) |UNAIDS |

| |UNAIDS | |

| |20 avenue Appia | |

| |CH – 1211 Geneva 27 | |

| |Tel: +41 22 791 1373 | |

| |Fax: +4122 791 4188 | |

| |E-mail: mantheyg@ | |

| | | |

|32. Patrick WHITAKER |Monitoring & Evaluation Team |UNAIDS |

| |(CRIS) | |

| |UNAIDS | |

| |20 avenue Appia | |

| |CH – 1211 Geneva 27 | |

| |Tel: +41 22 791 1372 | |

| |Fax: +4122 791 4188 | |

| |E-mail: whitakerp@ | |

| | | |

|33. Karianne BYE |Monitoring & Evaluation Team |UNAIDS |

| |(CRIS) | |

| |UNAIDS | |

| |20 avenue Appia | |

| |CH – 1211 Geneva 27 | |

| |Tel: +41 22 791 1359 | |

| |Fax: +4122 791 4188 | |

| |E-mail: byek@ | |

| | | |

|34. Catherine HANKINS |Strategic Information |UNAIDS |

| |UNAIDS | |

| |20 avenue Appia | |

| |CH – 1211 Geneva 27 | |

| |Tel: +41 22 791 3865 | |

| |Fax: +4122 791 4898 | |

| |E-mail: hankinsc@ | |

| | | |

|35. Karen STANECKI |Epidemic & Impact Monitoring Team |UNAIDS |

| |UNAIDS | |

| |20 avenue Appia | |

| |CH – 1211 Geneva 27 | |

| |Tel: +41 22 791 1662 | |

| |Fax: +4122 791 4898 | |

| |E-mail: staneckik@ | |

| | | |

|36. Reeta BHATIA |UN System Programme Review |UNAIDS |

| |UNAIDS | |

| |20 avenue Appia | |

| |CH – 1211 Geneva 27 | |

| |Tel: +41 22 791 1371 | |

| |Fax: +4122 791 4768 | |

| |E-mail: bhatiar@ | |

|37. Karl-Lorenz Dehne |Dr Karl-Lorenz Dehne |UNAIDS |

| |UNAIDS | |

| |Vienna International Center, Room D1470 | |

| |Wagramer Strasse 5, | |

| |A-1400 Vienna, Austria | |

| |Tel: +43 1 26060 4662 | |

| |Fax: +43 1 26060 7549 | |

| |E-mail: | |

| |Karl-Lorenz.Dehne@ | |

ANNEX 4

MONITORING AND EVALUATION REFERENCE GROUP (MERG)

7th MERG Meeting in Geneva, Switzerland (WHO-Room D) on 28-29 July 2003

UNABLE TO ATTEND

|Name |Contact details |Organization/Country |

| |

|NATIONAL GOVERNMENTS |

|1. Sylvia ANIE |Ghana AIDS Commission |GAC |Ghana |

| |P.O. Box CT 5169 | | |

| |Cantonments | | |

| |Accra | | |

| |Ghana | | |

| |Tel: +233 21 782 262 /263 | | |

| |Fax: +233 21 782 264 | | |

| |E-mail: dranie@.gh | | |

| | | | |

| |

|BILATERAL AGENCIES/NATIONAL GOVERNMENT AGENCIES/ |

|US FUNDED PROJECTS |

|2. Phil COMPERNOLLE |Health and HIV |DFID |UK |

| |Evaluation – HIV/AIDS | | |

| |Department for International Development | | |

| |London | | |

| |UK | | |

| |Tel: +44 1355 843640 | | |

| |Fax: | | |

| |E-mail: P-Compernolle@.uk | | |

| | | | |

|3. Valerie YOUNG |Performance Review Branch |CIDA |Canada |

| |Canadian International Development Agency | | |

| |200 Promenade du Portage | | |

| |Hull, Quebec K1A 0G4, Canada | | |

| |Tel : +819 994 6137 | | |

| |Fax : +819 953 9130 | | |

| |E-mail : | | |

| |valerie_young@acdi-cida.gc.ca | | |

|4. George BICEGO |Global AIDS Program |CDC |USA |

| |Centers for Disease Control and Prevention | | |

| |1600 Clifton Road. NE | | |

| |Atlanta, GA 30333 | | |

| |USA | | |

| |Tel: +1 404 639-3534 | | |

| |Fax: +1 404 639 4268 | | |

| |E-mail : gpb4@ | | |

|5. John STOVER |The Futures Group International |Futures |USA |

| |80 Glastonbury Blvd. |Group | |

| |Glastonbury, Connecticut 06033 | | |

| |USA | | |

| |Tel: +1 860 633 3501 | | |

| |Fax: +1 860 657 3918 | | |

| |E-mail: j.stover@ | | |

| |

|ACADEMIC/RESEARCH INSTITUTES |

|6. Eiliana MONTERO-ROJAS |Escuela de Estadística |University of Costa |Costa Rica |

| |Universidad de Costa Rica |Rica | |

| |San José, | | |

| |Costa Rica | | |

| |Central America | | |

| |Tel: +506 280-5194 | | |

| |Fax: +506 207 4809 | | |

| |E-mail: emontero@cariari.ucr.ac.cr | | |

|7. Françoise DUBOIS-ARBER |University Institute of Social and Preventive |IUMSP |Switzerland |

| |Medicine, | | |

| |University of Lausanne | | |

| |17 rue du Bugnon, | | |

| |CH-1005 Lausanne | | |

| |Switzerland | | |

| |Tel: +41 21 314 7292/90 | | |

| |Fax: +41 21 314 7244 | | |

| |E-mail: fdubois@inst.hospvd.ch | | |

|8. Kong-lai ZHANG |Department of Epidemiology |PUMC |China |

| |Peking Union Medical College | | |

| |5 Dong Dan San Tiao | | |

| |Beijing | | |

| |China 100005 | | |

| |Tel: +86 10 652 96973 | | |

| |Fax: +86 10 652 88170 | | |

| |E-mail: klzhang@ | | |

|9. Napaporn HAVANON |Department of Graduate School | |Thailand |

| |Sri Nakharinwirot University | | |

| |Sukhumvit Soi 23 | | |

| |Bangkok | | |

| |Tel/Fax: 662 258 4119, 260 0133 | | |

| |E-mail: napaporn@swu.ac.th | | |

| |E-mail : knowledge_swu@ | | |

|COSPONSORS |

|10. To be identified |Division for Operations and Analysis |UNDCP |

| |United Nations International Drug Control Program | |

| |P.O. Box 500 | |

| |Vienna A1400 | |

| |Austria | |

| |Tel: +43 1 26060 5450 | |

| |Fax: +43 1 26060 5896 | |

| |E-mail: | |

|11. Benjamin ALLI |Technical Cooperation |ILO |

| |International Labour Office | |

| |4, route des Morillons | |

| |CH-1211 Geneva 22 | |

| |Tel: +4122 799 6438 | |

| |Fax: +4122 799 6668 | |

| |Email: alli@ | |

|12. Susan STOUT |Monitoring and Evaluation |World Bank |

| |Support Team | |

| |Global HIV/AIDS Office | |

| |The World Bank | |

| |1818 H. Street, N.W. | |

| |Washington D.C. 20433 | |

| |USA | |

| |Tel: +1 202 458 2537 | |

| |Fax: +1 202 522 7396 | |

| |E-mail: sstout@ | |

| |

|NON GOVERNMENTAL ORGANIZATIONS |

|13. Jacqueline BATARINGAYA |ActionAid Africa |ActionAid |Zimbabwe |

| |Regional Office |International | |

| |16 York Avenue | | |

| |Newlands | | |

| |Harare | | |

| |Zimbabwe | | |

| |Tel: +263 4 788122/3 | | |

| |Fax: +263 4 788 124 | | |

| |E-mail: bataringayaj@.zw | | |

| |

|EUROPEAN UNION |

|14. Charles TODD |Human and Social Development Unit (B/3) |EU |Belgium |

| |DG Development | | |

| |European Commission | | |

| |B-1049 | | |

| |Bruxelles | | |

| |Belgium | | |

| |Tel: +32-2-299-0289 | | |

| |Fax: +32-2-296-3697 | | |

| |E-mail: Charles.TODD@cec.eu.int | | |

................
................

In order to avoid copyright disputes, this page is only a partial summary.

Google Online Preview   Download